AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox

Merck & Co reported an 11.4% stake in EVAX as of December 21, 2023. This is likely causing the stock to rise as a large firm like Merck investing in the company brings legitimacy and potential for partnership or acquisition in the future. Additionally, EVAX announced the completion of changing their ADS ratio which could make the stock more accessible to smaller investors


Knowing stock market today at a glance

Nov.06 2025

Nov.06 2025

Nov.06 2025

Nov.06 2025

Nov.06 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet